{"title":"Fulminating COVID‐19 infection: my personal experience","authors":"G. Hackett","doi":"10.1002/tre.838","DOIUrl":null,"url":null,"abstract":"The author takes us on a very personal journey through his experience of a severe COVID‐19 infection, hospitalisation and subsequent recovery, along with the sequelae. His experience and subsequent research have left him convinced of the value of phosphodiesterase type‐5 inhibitors and testosterone in the treatment of men hospitalised with COVID‐19.","PeriodicalId":42819,"journal":{"name":"Trends in Urology & Mens Health","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in Urology & Mens Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/tre.838","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
The author takes us on a very personal journey through his experience of a severe COVID‐19 infection, hospitalisation and subsequent recovery, along with the sequelae. His experience and subsequent research have left him convinced of the value of phosphodiesterase type‐5 inhibitors and testosterone in the treatment of men hospitalised with COVID‐19.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
